Guardant Health
GH
#2394
Rank
HK$48.37 B
Marketcap
HK$391.49
Share price
5.46%
Change (1 day)
108.67%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: HK$48.37 Billion

As of January 2025 Guardant Health has a market cap of HK$48.37 Billion. This makes Guardant Health the world's 2394th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$48.37 B65.66%
2024HK$29.19 B13.87%
2023HK$25.64 B17.79%
2022HK$21.76 B-72.54%
2021HK$79.28 B-20.62%
2020HK$99.88 B74.78%
2019HK$57.14 B126.39%
2018HK$25.24 B

End of Day market cap according to different sources

On Jan 29th, 2025 the market cap of Guardant Health was reported to be:

HK$45.86 Billion
by Yahoo Finance info icon info icon
HK$45.86 Billion
by CompaniesMarketCap info icon info icon
HK$45.86 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$181.47 B 275.18%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$19.91 B-58.84%๐Ÿ‡บ๐Ÿ‡ธ USA